(Q53506738)

15 May 2018

editorial

0 references

title

miR-21 and cardiac fibrosis: another brick in the wall? (English)

1 reference

15 May 2018

author

Elena Cavarretta

series ordinal

1

1 reference

15 May 2018

Gianluigi Condorelli

series ordinal

2

1 reference

15 May 2018

publication date

13 May 2015

1 reference

15 May 2018

published in

European Heart Journal

1 reference

15 May 2018

volume

36

1 reference

15 May 2018

issue

32

1 reference

15 May 2018

page(s)

2139-2141

1 reference

15 May 2018

Fibrosis: ultimate and proximate causes

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

microRNAs in cardiovascular diseases: current knowledge and the road ahead.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV184

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHV184

1 reference

15 May 2018

1 reference

15 May 2018